SCHEMBL2858047

SCHEMBL2858047

CCCCc1ccc(C#Cc2ccc(CN(C(=O)CCCCCCC(=O)O)c3ccc(O)c(C(=O)O)c3)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 1/20 0.67
PTPRO Q16827 1/20 0.67
STAT3 P40763 6/20 0.59
KAT8 Q9H7Z6 2/20 0.47
LTB4R2 Q9NPC1 9/20 0.47
AGTR1 P30556 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1733830 0.95 PTPN11 (0.71) PTPN11PTPROSTAT3KAT8LTB4R2
SCHEMBL1733837 0.87 PTPN11 (0.60) PTPN11PTPROSTAT3LTB4R2AGTR1
SCHEMBL1734595 0.86 PTPN11 (0.66) PTPN11PTPROSTAT3KAT8LTB4R2
SCHEMBL2848964 0.85 PTPN11 (0.60) PTPN11PTPROSTAT3KAT8LTB4R2
SCHEMBL1735936 0.84 STAT3 (0.80) PTPN11PTPROSTAT3KAT8
SCHEMBL2851528 0.83 PTPN11 (0.68) PTPN11PTPROSTAT3KAT8LTB4R2
SCHEMBL13711772 0.83 PTPN11 (0.67) PTPN11PTPROSTAT3KAT8LTB4R2
SCHEMBL1734774 0.82 PTPN11 (0.66) PTPN11PTPROSTAT3KAT8LTB4R2
SCHEMBL1734726 0.82 PTPN11 (0.61) PTPN11PTPROSTAT3KAT8LTB4R2
SCHEMBL1733827 0.81 PTPN11 (1.00) PTPN11PTPROSTAT3KAT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1654247-B1 ALKYNYL ARYL CARBOXAMIDES MERCK SERONO SA (CH) 2010-01-20 EP claimed
US-7589232-B2 Alkynyl aryl carboxamides LABORATORIES SERONO S.A. (CH) 2009-09-15 US claimed
US-20070105913-A1 Alkynyl aryl carboxamides APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V. (NL) 2007-05-10 US claimed
EP-1654247-B1 ALKYNYL ARYL CARBOXAMIDES MERCK SERONO SA (CH) 2010-01-20 EP disclosed
EP-1654247-B1 ALKYNYL ARYL CARBOXAMIDES MERCK SERONO SA (CH) 2010-01-20 EP disclosed
US-7589232-B2 Alkynyl aryl carboxamides LABORATORIES SERONO S.A. (CH) 2009-09-15 US disclosed
US-7589232-B2 Alkynyl aryl carboxamides LABORATORIES SERONO S.A. (CH) 2009-09-15 US disclosed
US-7589232-B2 Alkynyl aryl carboxamides LABORATORIES SERONO S.A. (CH) 2009-09-15 US disclosed
US-20070105913-A1 Alkynyl aryl carboxamides APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V. (NL) 2007-05-10 US disclosed
US-20070105913-A1 Alkynyl aryl carboxamides APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V. (NL) 2007-05-10 US disclosed
US-20070105913-A1 Alkynyl aryl carboxamides APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V. (NL) 2007-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105913-A1 Alkynyl aryl carboxamides ECHS1, IRS1, HCCS PTPN11 97/4885PTPRO 51/4885STAT3 2684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.